INTRODUCTION
During chronic HIV infection, multiple mechanisms combine to ensure the persistence of virus-infected CD4 T cells despite innate and adaptive antiviral responses. Foremost among these is ongoing virus replication, which by itself can maintain an infected CD4 T cell pool in the absence of antiretroviral therapy (ART) (Ho et al., 1995) . Even under ART, however, HIV-infected CD4 T cells remain detectable in blood and lymphoid tissue. This may partly reflect the persistence of memory cells that harbor replicationcompetent proviruses for long periods without expressing them (Chun et al., 1997a (Chun et al., , 1997b Finzi et al., 1997 Finzi et al., , 1999 Hermankova et al., 2003; Wong et al., 1997) . That such cells can show a resting memory phenotype has led to their identification as a latent reservoir and has spurred development of ''shock and kill'' HIV cure strategies (Archin et al., 2012; Rasmussen et al., 2014; Routy et al., 2012; Søgaard et al., 2015; Spivak et al., 2014) . Nevertheless, recent studies have also demonstrated clonal expansion of HIV-infected CD4 T cells under ART (Cohn et al., 2015; Maldarelli et al., 2014; Simonetti et al., 2016; Wagner et al., 2014) , raising questions about the intrinsic properties of infected cells in this setting (Kim and Siliciano, 2016) . The further characterization of mechanisms by which HIV-infected CD4 T cells persist under different conditions in vivo has thus emerged as a key research goal.
Here, we investigated the mechanisms that maintain HIV in vivo through a detailed genetic analysis of virus sequences from CD4 T cell subsets in blood and lymphoid tissue. We chose people with natural control of the virus for this study. These individuals, termed HIV controllers, represent a rare group whose HIV-specific immune responses enable them to control the virus without ART (Migueles and Connors 2015; Walker and Yu, 2013) . Despite evidence of ongoing virus replication in HIV controllers not receiving ART (Boufassa et al., 2014; Chun et al., 2013; Fukazawa et al., 2015; Hatano et al., 2013; Mens et al., 2010; O'Connell et al., 2010; Salgado et al., 2010) , prior work has shown fewer CD4 T cells containing HIV DNA (Julg et al., 2010) and replication-competent HIV (Blankson et al., 2007) in HIV controllers than in non-controllers. We reasoned that this would allow us to sample more of the total virus population in these individuals and therefore obtain a comprehensive view of the infected CD4 T cell pool. Thus, we used sequencing not only to help infer mechanisms of HIV persistence during natural virologic control, but also to elucidate cellular processes that may maintain the virus both in HIV controllers and in non-controllers.
RESULTS

Distribution of HIV among Blood CD4 T Cell Subsets in HIV Controllers
We enrolled 14 HIV controllers, defined by plasma HIV RNA levels <1,000 copies/ml during chronic infection without ART, as well as six non-controllers with plasma HIV RNA levels >10,000 copies/ml off ART (Table S1 ). Participants had been documented HIV seropositive for a median of 15.5 years, with a median of 18 years in the controller group (range 4-30) and 6 years in the non-controller group (range 2-29; Mann-Whitney p = 0.1040 for controllers versus non-controllers). Seven of 14 controllers and two of six non-controllers carried protective class I major histocompatibility complex (MHC) alleles including multiple HLA-B57 subtypes and HLA-B2703. Blood CD4 T cell counts were higher in the controllers than in the non-controllers (Mann-Whitney p = 0.0064).
We first characterized naive (T N ), central memory (T CM ), transitional memory (T TM ), and effector memory (T EM ) CD4 T cells in blood as hosts for the virus in these individuals by quantifying HIV nucleic acids in cell subsets sorted by fluorescence-activated cell sorting (FACS) ( Figure S1 ). In HIV controllers, fluorescence-assisted clonal amplification (FCA; Figure S2 ) revealed that T EM and T TM cells were more likely to contain HIV DNA ex vivo than were T CM cells ( Figure 1A ). By adjusting for absolute cell numbers and assuming one copy of HIV DNA per infected cell, we also found that the T EM and T TM subsets accounted for most of the infected CD4 T cells in blood in HIV controllers ( Figure 1B) , with a median 72.6% of total HIV DNA copies in T EM cells and a median 21.2% in T TM cells. Although we hypothesized that this characteristic distribution in HIV controllers reflected greater HIV expression and replication within T EM -and T TM -like cells in vivo, qRT-PCR revealed low or undetectable levels of unspliced and spliced HIV RNA in all CD4 T cell subsets from these individuals ( Figure 1C ). We also found no correlation across individual HIV controllers between the level of HIV genomic DNA in each subset and the absolute count of each subset in blood (T CM , Spearman r = À0.200, p = 0.492; T TM , r = À0.477, p = 0.087; T EM , r = 0.033, p = 0.916), as might have been expected with ongoing, active replication and resulting cell depletion.
HIV DNA Sequence Analysis in Blood CD4 T Cell Subsets in HIV Controllers
To clarify the roles of circulating CD4 T CM , T TM , and T EM cells as hosts for the virus in HIV controllers, we sequenced the single-template PCR products derived by FCA from these cell subsets and plasma virions. Compared to 608 HIV sequences from the non-controllers, the 1,279 sequences from the HIV controllers showed two striking patterns (compare Figures  S3 and S4) . First, blood CD4 T cell-associated HIV sequences in each HIV controller differed markedly from that individual's plasma virus sequences. HIV sequences in blood CD4 T cells from HIV controllers rarely matched plasma viruses (Figure 2A ). Although genetic distances among HIV sequences might be expected to be greater in non-controllers than in controllers due to higher levels of virus replication in non-controllers, the genetic distances between cell-associated virus DNA sequences and plasma viruses in controllers were as great as those in non-controllers ( Figure 2B ). The large genetic distances observed in controllers were not due to dual infections because sequences from all study participants were genetically clustered by participant ( Figure 2C ). Moreover, whereas HIV DNA sequences in blood cells from non-controllers were genetically intermingled with plasma viruses, HIV DNA sequences in blood cells from controllers were frequently compartmentalized from plasma viruses ( Figure 2D ). This was especially true in the T EM subset, where compartmentalization from plasma viruses was seen in 13/14 controllers but only in one of six noncontrollers.
In addition to genetic divergence from plasma viruses, HIV DNA sequences in blood cells from controllers showed large clusters of identical sequences not commonly seen in non-controllers. As measured by normalized Shannon diversity, which increases with the proportion of unique sequences in a population, HIV DNA sequences were less diverse in controllers than in noncontrollers within each CD4 T cell subset ( Figure 2E ). This was true despite similar levels of diversity in plasma viruses from the two groups ( Figure 2E ). Clusters of identical sequences were particularly prominent in T EM cells from controllers, with lower HIV diversity in T EM cells than in T TM or T CM cells ( Figure 2E ). Diversity of HIV DNA sequences in non-controllers was similar among T CM , T TM , and T EM subsets ( Figure 2E ). Thus, among memory CD4 T cell subsets in HIV controllers, the T EM subset accounted for most of the infected cells in blood but generally harbored proviruses that were transcriptionally quiescent, markedly distinct from plasma viruses, and rich in clusters of identical sequences. HIV Clonality in Blood CD4 T Cell Subsets from HIV Controllers Based on these results, we hypothesized that each cluster of identical HIV DNA sequences represented one CD4 T cell clone harboring a single HIV provirus amplified in vivo through cell proliferation. We also hypothesized that the T EM subset might be enriched for recurrent HIV sequences because memory CD4 T cells undergoing clonal expansion in vivo tend to differentiate into T EM cells. To test this, we first compared the clonotypic diversity of the three memory CD4 T cell subsets using T cell other hypermutated sequences are omitted for clarity. The large sequence cluster in participant S1349 is shown separated from the tree for ease of viewing; an arrowhead shows the position of this sequence on the tree. See also Table S2. receptor beta chain (TCRB) deep sequencing. We found that TCRB diversity decreased progressively along the putative pathway of differentiation from T CM to T TM to T EM ( Figure 3A) , consistent with the hypothesis. We evaluated the alternative explanation for clusters of identical HIV DNA sequences in blood cells, whereby sequences closely related to the actively replicating virus pool and matching over the region we sequenced might accumulate through bursts of virus replication. Using plasma viruses as a genetic surrogate for actively replicating viruses, we observed the opposite pattern. In general, HIV sequences from blood T CM , T TM , and T EM cells in HIV controllers were ancestral to plasma viruses ( Figure 3B ). Sequences occurring at least twice rarely matched any plasma virus sequence ( Figure 3C ). Moreover, recurrent sequences that accounted for higher copy numbers in blood (i.e., occurred in more cells) were genetically more distant from plasma viruses ( Figure 3D) , with average genetic distances to plasma viruses frequently >5%. This suggested greater expansion among older HIV-infected CD4 T cell clones in HIV controllers, which was not apparent in sequences from non-controllers (Spearman r = À0.2706, p = 0.2117; data not shown). Therefore, recurrent HIV DNA sequences in blood CD4 T cells from HIV controllers had genetic attributes of expanded cellular clones rather than virus replicative bursts.
We used HIV integration site analysis to prove the presence of clonally expanded, HIV-infected cells in blood from HIV controllers. Although too few infected cells to permit this analysis were available from some participants, we identified two HIV integration sites in clonally expanded cells for participant V907 and one such site for participant S1349. We then linked recurrent env sequences with their integration sites by PCR from the forward env primer to the integration site. Sequencing the env portions of these amplicons confirmed that clusters of identical sequences detected by FCA arose from expanded CD4 T cell clones (Figures 3E and 3F) . These clones accounted for 91.3% and 95.5% of all amplifiable env DNA copies in blood CD4 T cells from these participants. Therefore, integration site analysis in HIV controllers confirmed both the presence of clonally expanded, HIV-infected cells and the predominance of these cells within the circulating, HIV-infected CD4 T cell pool.
We next characterized further the recurrent HIV DNA sequences detected in blood cells within the full HIV controller cohort. Excluding the six of 105 such sequences with <1% genetic distance from plasma viruses as possible replicative bursts, we analyzed the remaining 99 as coming from presumptive expanded clones (Table S2 ). These sequences were relatively abundant in blood, together accounting for between 32.7% and 96.8% of HIV DNA sequences in circulating CD4 T cells from each individual, at levels ranging between 0.32 and 1368.61 copies/ml for each sequence. Twenty-two of these sequences (22.2%) contained one or more stop codon associated with G-to-A hypermutation, and an additional sequence contained a frameshift in gp120. The remaining 76 sequences (76.8%) contained neither stop codons nor frameshifts over the region of env sequenced (HXB2 bases 7011-7502). We found 32 (32.3%) of these sequences in more than one memory CD4 T cell subset ( Figure 4A ) and many of these in multiple subsets within T CM , T TM , and T EM defined by the markers CCR6, CXCR5, and CD57 ( Figure 4B ). Therefore, confirmed and 
V907_25 V907_16 S1475_18 S1492_23 S1492_42 S1495_30 S1495_14 S1495_32 S1495_43 S1548_44 S1548_24 S1548_31 S1548_28 S1548_34 S1548_22 S1548_48 S1548_43 Table S2. presumptive HIV-infected CD4 T cell clones in blood from HIV controllers showed evidence of in vivo maturation and functional differentiation. Finally, although repeated and hypermutated sequences accounted for a strikingly high proportion of all HIV DNA copies in blood CD4 T cells from HIV controllers, equal or higher absolute numbers of these sequences were detected in blood CD4 T cells from non-controllers ( Figure 4C ).
Inducible Proviruses in Blood CD4 T Cells from HIV Controllers
Because some expanded HIV DNA sequences may have been lethally mutated outside the region we sequenced, we tested whether CD4 T cells harboring these sequences could produce virions by stimulating them through the T cell receptor and then sequencing RNA from virions released in culture.
Although these experiments revealed no virion production from most presumptive expanded clones ( Figure S5 , open bars), we recovered virion RNA matching two recurrent DNA sequences from T EM cells in participant S1270 ( Figure S5 , filled bars; Figure 5A , x-y plots, filled circles). One of these DNA sequences was highly expanded, divergent from plasma viruses, and close to the most recent common ancestor (MRCA), consistent with an expanded clone carrying an archival provirus. The other appeared to be more recent (arrowhead) but contained a frameshift in gp120. Importantly, while abundant virion production was again detected from cells harboring the latter sequence in a repeat experiment, this was not the case for cells harboring the former sequence, even though this sequence occurred within many more cells in the culture ( Figure 5B ). Therefore, although virion production was occasionally inducible from proviruses bearing genetic signatures of expanded cellular clones, the inducibility of a given provirus was not always uniform among the cells that harbored it. Importantly, we also detected a second class of inducible viruses with a distinct genetic signature in these experiments. In participants S1495, V912, and S1349, we found multiple induced viruses that had not been detected as recurrent DNA sequences in separate aliquots of the same cell populations (stars in Figure 5A, x-y plots). All but one of these ''unique induced'' viruses were closely related to plasma viruses and divergent from ancestral sequences, suggesting recent in vivo infection of the cells producing them. Assuming that recurrent virion RNA copies of unique induced sequences represented progeny virions from one cell, we calculated that cells harboring these proviruses accounted for 0.19%-1.48% of all HIV-infected, circulating memory CD4 T cells from the individuals in whom they were detected ( Figure 5A, hemispheres) . Of note, unique induced viruses were detected in all circulating memory CD4 T cell subsets and were found mainly in the two HIV controllers with the highest plasma viremia. Overall, therefore, inducible proviruses in circulating memory CD4 T cells from HIV controllers fell into two distinct categories: expanded, archival proviruses in T EM cells, and proviruses of recent origin in rare T CM , T TM , and T EM cells.
Lymphoid Tissue Viruses in HIV Controllers
To help determine the origin of circulating CD4 T cells harboring unique induced viruses in HIV controllers, we characterized HIV in lymph node (LN) from four study participants (Table S3) . Three of these four had detectable plasma viremia and showed high levels of HIV DNA in LN CD4 T cells. In these viremic HIV controllers, the highest levels of HIV DNA were observed in germinal center (GC) and non-germinal center (non-GC) T FH cells (Figure 6A ). These T FH subsets accounted for 73.1%-86.3% of the infected CD4 T cells in LN ( Figure 6D ). However, HIV-infected cells were also detected in LN T CM , CD57 + , and T EM subsets, at levels that were higher than in T CM , T TM , and T EM cells from blood ( Figure 6A ). HIV DNA in both follicular and non-follicular LN memory CD4 T cells was also associated with higher HIV RNA levels than was HIV DNA in blood cells ( Figures 6B and  6C ). Detection of cell-associated HIV RNA by in situ hybridization using intact LN tissue samples confirmed that HIV RNA + LN cells were present both inside and outside follicles in these individuals ( Figure 6E ). To clarify the relationship of HIV in T FH and non-T FH LN cells to viruses in blood cells and plasma, we analyzed HIV DNA sequences in LN cell subsets. We found that sequences from GC and non-GC T FH cells in the three viremic controllers (n = 113 sequences) were more closely related to plasma viruses than were HIV DNA sequences from blood cells ( Figure 7A , left panels). In two participants, sequences in T FH cells were also significantly further from the MRCA than were blood cell-associated sequences. Although recurrent HIV DNA sequences were observed in T FH cells, these sequences too were closely related to plasma viruses and divergent from ancestral sequences, thus distinguishing them from recurrent HIV DNA sequences in blood cells. Importantly, analysis of 145 additional sequences from non-T FH T CM and T EM LN cells in these individuals showed a close relationship with viruses in T FH cells ( Figure 7A , right panels, green symbols). By contrast, the sequences from circulating T CM , T TM , and T EM cells were significantly more distant from viruses in T FH cells ( Figure 7A , right panels, red symbols). Thus, among CD4 T cells of a given maturation phenotype, we identified sharp distinctions in the genetic characteristics and transcriptional activity of cell-associated HIV populations detected in different anatomic sites. Whole-transcriptome sequencing and principal component analysis (PCA) of cell subsets from these sites revealed that LN T EM cells had a transcriptional profile that was related to that of T FH cells and distinct from that of circulating CD4 T EM cells ( Figure 7B ).
Finally, in one HIV controller with undetectable plasma viremia, levels of LN cell-associated HIV DNA were nearly undetectable (Table S3) . In this individual, only a single, G-to-A-hypermutated copy of HIV was detected among all LN CD4 T cells studied, with no HIV DNA found in >2 3 10 4 T FH and GC T FH ( Figure S6I ). Flow cytometry confirmed the expected distribution of LN CD4 T cells among T N , T FH , and other memory subsets in this individual (Figures S6A-S6H ). Furthermore, plasma virus sequences from this individual showed a relatively high average intragroup pairwise genetic distance ( Figure S6J ) and an average divergence from MRCA that was the highest out of all 20 participants ( Figure S6K ). Therefore, HIV-infected CD4 T cells were very rare in LN from one HIV controller even though plasma viruses showed genetic markers of diversification and ongoing evolution. This individual also showed T CM cell-associated HIV DNA sequences in blood that were more genetically distant from plasma viruses than were T EM -associated sequences. Among all 14 HIV controllers studied, the relative genetic proximity of T CM -associated HIV DNA sequences to plasma viruses was directly associated with plasma viremia ( Figure S7 ).
DISCUSSION
In this study, we investigated the mechanisms of virus persistence in HIV controllers using a combination of genetic analyses to track HIV replication and the persistence of HIV-infected cells in vivo. We found that the populations of HIV-infected CD4 T cells in blood and lymphoid tissue from these individuals differed markedly from one another. The infected cell pool in blood largely comprised archival proviruses within highly differentiated cells that appeared to be clonally expanded and that occasionally expressed virions when stimulated. In sharp contrast, the lymphoid tissue was often rich in T FH and other memory CD4 T cells bearing HIV genetic markers of recent infection and containing abundant virus transcripts. Despite these differences, however, we also detected rare circulating CD4 T cells that inducibly expressed HIV proviruses with the genetic signature of an actively replicating virus pool. These cells link the infected populations from blood and lymphoid tissue and may thus reflect the hematogenous dissemination of newly infected cells. Therefore, our findings suggest a single model in which HIV persists despite natural virologic control by three interrelated mechanisms:
(1) ongoing infection of cells in lymphoid tissue, (2) survival and recirculation of some of these cells, and (3) long-term persistence of proviruses in clonally expanded cells.
Our results support this model through key advances in several areas. Consistent with previous studies of SIV-infected macaques and HIV-infected long-term nonprogressors (Fukazawa et al., 2015; Perreau et al., 2013) , we detected viruses with genetic and transcriptional markers of active replication most abundantly within PD1 high , T FH -enriched cell populations in hosts who control the virus spontaneously. However, by using single-copy sequence analysis to identify this virus population, we were also able to detect its dissemination to extrafollicular LN cells. This implies either HIV transmission across follicle boundaries or differentiation of infected T FH cells into non-T FH cells. Furthermore, the genetic similarity among plasma viruses, viruses in LN cells, and unique induced viruses from blood cells suggests that some infected LN cells survive their initial encounter with infectious virus long enough to recirculate. We also identified blood T EM cells that appeared to be clonally expanded as a source of archival virus in HIV controllers. Our finding that inducible proviruses of recent origin were present but rare amid the excess of archival proviruses in highly differentiated, clonally expanded blood cells explains the large genetic distance between HIV sequences in blood cells and plasma observed previously in controllers (Bailey et al., 2006; O'Connell et al., 2010) . Finally, although prior studies have found expanded clones of HIV-infected cells ex vivo (Cohn et al., 2015; Maldarelli et al., 2014; Wagner et al., 2014) , virus production has been shown previously from only one clone in one individual (Maldarelli et al., 2014; Simonetti et al., 2016) and never in an HIV controller. Although CD4 T cell clonal proliferation may involve transcriptional processes that elicit HIV expression and thus select for lethal mutations among expanded proviruses, the dissociation of virion production from cellular stimulation supported by our findings provides one mechanism for proliferative self-renewal of HIV-producing CD4 T cells in vivo.
The heterogeneity that we observed among HIV-infected T EM cells from HIV controllers was also noteworthy. Most HIV DNA sequences in circulating T EM cells appeared to be associated with expanded cellular clones. We propose that this reflects the basic biology of T EM cells, which may also harbor infected cells that have clonally expanded in ART-treated individuals (von Stockenstrom et al., 2015) . The relatively high levels of HIV DNA we found in blood T EM cells distinguish HIV controllers from ART-treated individuals (Chomont et al., 2009 ) and may stem from higher levels of virus replication and immune activation (Hunt et al., 2008 (Hunt et al., , 2011 Krishnan et al., 2014) stimulating HIV-infected cells to proliferate and differentiate in HIV controllers. At the same time, by sampling lymphoid tissue or virions induced from blood cells instead of blood cell DNA, we uncovered viruses of recent origin in rare T EM cells. Therefore, it appears that both archival and actively replicating virus populations persist within T EM cells in HIV controllers, but by distinct mechanisms. Importantly, lack of CD27 expression represents an inclusive definition for the T EM subset, and finer distinctions among subsets of CD27 -cells may yield additional insights in future studies. Furthermore, the lifespan of circulating CD27 -cells carrying inducible, recently acquired proviruses remains to be determined. Nonetheless, these considerations make clear that targeting less differentiated T CM and T TM cells is unlikely to eliminate all potentially infectious proviruses in HIV controllers.
Despite these diverse mechanisms of persistence, we detected profound imprints of effective antiviral defenses among HIV DNA sequences from HIV controllers. In peripheral blood, restricted replication of the virus was associated with a predominance of recurrent sequences within clonally expanded cells, a scarcity of cell-associated virus transcripts, and a small number of cells harboring unique induced viruses. While expanded G-to-A hypermutant viruses were abundant in circulating infected cells from some HIV controllers, this most likely reflects a predominance of non-replicating proviruses in these individuals, rather than excess activity of APOBEC3G (Abdel-Mohsen et al., 2013) . In lymphoid tissue, the enrichment for recently infected cells containing abundant HIV transcripts within T FH populations is consistent with a key role for virus-specific CD8 + T cells in suppressing HIV replication outside follicles (Fukazawa et al., 2015) . In fact, we documented this effect in individuals lacking major protective HLA-B alleles, suggesting that the suppression of extrafollicular virus replication may occur widely among HIV controllers. Finally, we propose that the relationship between plasma viremia and the genetic proximity of blood T CMassociated HIV DNA sequences to plasma viruses in HIV controllers reflects reduced dissemination of recently infected CD4 T cells in individuals with greater virologic control. When ongoing virus replication is very limited, rare recently infected cellsmore readily detected by sequencing in the T CM subset than in the more heavily expanded T TM and T EM subsets-may occur too rarely for detection in a single blood sample. Taken to an extreme, the limited dissemination of recently infected CD4 T cells in blood may prevent the virus from spreading throughout the lymphoid tissue compartment, as for one participant in our study. Thus, in rare cases, natural antiviral responses may restrict the regional anatomic distribution of the virus.
Our findings reflect in vivo properties of HIV-infected CD4 T cell populations that may be generalizable to all infected individuals. Of particular interest is the uncertain significance of expanded CD4 T cell clones as barriers to cure. On the one hand, the rarity of virion production from expanded proviruses in our study mirrors results in ART-treated individuals, calling into question whether this mechanism alone could account for the near certainty of rebound viremia upon ART interruption. On the other hand, the recent temporal clustering of unique induced proviruses in our study suggests that newly infected cells recirculating from lymphoid tissue may disappear quickly if not maintained by clonal expansion. Complicating attempts to resolve these findings, however, is the evident difficulty of eliciting virus expression from some inducible proviruses in HIV controllers, as shown previously in ART-treated non-controllers (Ho et al., 2013) . In addition to preventing full characterization of inducible proviruses ex vivo, this difficulty may reflect natural heterogeneity in the cellular response to stimulation that serves to protect some proviruses from antiviral defenses in vivo. Therefore, while our findings support the role of the B cell follicle in ongoing HIV replication in HIV controllers, we also demonstrate extrafollicular mechanisms that could maintain and disseminate the virus even if its replication inside follicles were disrupted. Were any approach to a functional or sterilizing cure to succeed either in HIV controllers or in non-controllers, it would need to target these multiple distinct cellular processes.
EXPERIMENTAL PROCEDURES
Peripheral Blood Mononuclear Cell and LN Samples Participants were recruited from UCSF and NIAID and gave informed consent for all procedures. Studies were approved by the UCSF and NIAID institutional review boards. Peripheral blood mononuclear cells (PBMCs) were isolated from blood or leukapheresis by density gradient centrifugation. LN excisional biopsy samples were sectioned and filtered to generate single-cell suspensions.
Fluorescence-Activated Cell Sorting Viable PBMCs were stained and sorted on a FACSAria (BD). Subset definitions were as shown in Figure S1 for PBMCs and in Figure S6 for LN cells.
Nucleic Acid Extraction RNA and DNA were extracted in separate fractions from sorted cells lysed in RNAzol RT (MRC), according to the manufacturer's instructions.
Recovery of HIV Virion RNA Virion RNA was extracted from whole plasma or pelleted virions using the QiaAmp vRNA mini kit (QIAGEN), according to the manufacturer's instructions.
Fluorescence-Assisted Clonal Amplification for Single-Copy HIV Quantification and Sequencing Cell DNA or reverse-transcribed HIV virion RNA was amplified at limiting dilution in replicate PCR wells using primers targeting HXB2 positions 6908-7517, with SYBR green I as marker of double-stranded DNA (dsDNA). Amplification was detected by real-time fluorescence and confirmed by melt curve ( Figure S2 ). Single copies of HIV DNA were enumerated for each sample by limiting dilution calculations. Amplified env products were reamplified by nested PCR and Sanger sequenced. Because all primers in these PCRs targeted regions within the HIV genome, the resulting sequence data were considered to reflect all HIV DNA copies in samples from cells, including both integrated and unintegrated forms.
Quantification of HIV RNAs
Cellular total RNA samples were tested for HIV RNA by qRT-PCR for unspliced (gag) RNA or transcripts spliced between the SD1 and SA4 sites (Purcell and Martin 1993) . Copies of RNA were enumerated using standard curves generated from dilutions of synthetic RNAs.
HIV Sequence Analysis
Sanger sequence reads defining single HIV sequences spanning HXB2 base positions 7011-7502 were edited, analyzed for diversity by subset within each participant, aligned by participant, and subjected to phylogenetic analysis after identification and removal of G-to-A hypermutated sequences.
T Cell Receptor Beta Gene Deep Sequencing
Sequencing and annotation of expressed TCRB genes were performed as described (Gros et al., 2014) . The normalized Shannon diversity was calculated for the set of TCRB sequences from each CD4 T cell subset by the same method used for populations of HIV sequences (see Supplemental Experimental Procedures), determining the maximum Shannon diversity for each sample based on the number of cells used in library preparation.
HIV Integration Site Deep Sequencing
Integration site analysis was performed as described (Maldarelli et al., 2014) .
Sequencing of Viruses Induced In Vitro
Sorted T CM , T TM , and T EM cells were stimulated in culture through the T cell receptor in the presence of antiretrovirals, and virions were pelleted from culture supernatants for RNA extraction after 4 and 8 days of culture. Virion RNA was reverse transcribed and amplified for single-copy sequencing by FCA.
In Situ Hybridization
Hybridization of 35 S-labeled riboprobes for the detection of HIV RNA + cells in LN tissue slices available from two study participants was performed as described (Rothenberger et al., 2015) .
Whole-Transcriptome Sequencing
Messenger RNA libraries were constructed as described (Sandler et al., 2014) and sequenced in 2-3-75-base, paired-end runs on an Illumina HiSeq. Highquality reads were mapped to the Hg19 reference using Tophat (v.2.0.8) with a reference annotation (Ensembl ''Homo_sapiens.GRCh37.74.gtf''). Samples with low map rates were discarded. Transcript abundance was determined with Cufflinks (v2.1.1). PCA was performed using ''princomp'' in the R ''stats'' package. The abundance of each transcript was log transformed before PCA.
To limit the influence of low transcript abundance levels, the level of each transcript was set to 1 if the measured level was <1.
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